Related Experiment Video
Updated: Jul 16, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Dysregulated growth factor gene expression is associated with tubulointerstitial apoptosis and renal dysfunction
S A Teteris1, S A Menahem, G Perry
1Department of Medicine, Central and Eastern Clinical School, Monash University, Prahran, Victoria, Australia.
Abstract:
Chronic renal disease is characterized by declining renal function, loss of intrinsic renal cells, and their replacement with fibrotic tissue. This study investigates apoptosis and its regulation in the context of chronic renal disease. RNA was extracted from renal biopsies from patients with various forms of chronic renal disease. Expression of genes of the Bcl-2 family, death receptor pathway, and growth factors were measured by reverse-transcription real-time polymerase chain reaction. Apoptosis was detected by the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling technique. Tubulointerstitial apoptosis was positively associated with tubulointerstitial injury and renal dysfunction and increased 2.3-fold per unit (U) increase in transforming growth factor beta(1) (TGFbeta(1)) mRNA (P<0.05). Conversely, a 1 U increase in epidermal growth factor (EGF) mRNA was associated with a 47% decrease in tubulointerstitial apoptosis (P<0.05). Tubulointerstitial injury was correlated with increased TGFbeta(1) and tumour necrosis factor alpha (TNFalpha) mRNA (P<0.005) and decreased EGF mRNA (P<0.05). Additionally, for a 10 U decrease in the glomerular filtration rate there was an estimated increase of 5 and 10% in TGFbeta(1) and TNFalpha mRNA, respectively (P<0.05), whereas EGF mRNA decreased by an estimated 15% (P<0.005). Therefore dysregulation of cytokine/growth factor expression plays a central role in the progression of chronic renal disease through contribution to renal cell loss, tubulointerstitial injury, and renal dysfunction.
Insights
Dysregulation of growth factors like TGF-beta1 and EGF impacts chronic kidney disease progression. Increased TGF-beta1 and TNF-alpha, and decreased EGF, correlate with renal cell loss and dysfunction.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Chronic renal disease involves progressive loss of kidney function and cellular replacement by fibrosis.
- Apoptosis, or programmed cell death, is a key process implicated in the pathogenesis of chronic kidney disease.
- Understanding the molecular mechanisms regulating apoptosis is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the role of apoptosis and its regulation in chronic renal disease.
- To examine the expression of apoptosis-related genes and growth factors in renal biopsies.
- To determine the association between apoptosis, tubulointerstitial injury, and renal dysfunction.
Main Methods:
- RNA extraction from renal biopsies of patients with chronic renal disease.
- Measurement of gene expression for Bcl-2 family, death receptor pathway, and growth factors using RT-qPCR.
- Detection of apoptosis via terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) assay.
Main Results:
- Tubulointerstitial apoptosis showed a positive correlation with tubulointerstitial injury and renal dysfunction.
- Increased transforming growth factor beta(1) (TGFbeta(1)) mRNA was associated with higher apoptosis rates.
- Increased epidermal growth factor (EGF) mRNA was associated with decreased apoptosis rates.
- Tubulointerstitial injury correlated with elevated TGFbeta(1) and tumor necrosis factor alpha (TNFalpha) mRNA and reduced EGF mRNA.
- Declining glomerular filtration rate was linked to increased TGFbeta(1) and TNFalpha mRNA and decreased EGF mRNA.
Conclusions:
- Dysregulation of cytokine and growth factor expression is central to chronic renal disease progression.
- Altered expression of TGFbeta(1), TNFalpha, and EGF contributes to renal cell loss, injury, and dysfunction.
- Targeting these molecular pathways may offer novel therapeutic approaches for chronic kidney disease.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Diabetic Nephropathy
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...